---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-177777"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:33:01.619389+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Anand Shah resigns from board of Adagio Therapeutics, effective June 22, 2022

## Summary
- Anand Shah, M.D. resigned from the board of directors and all committees.
- Resignation effective immediately after the 2022 annual meeting on June 22, 2022.
- No reason for the departure was disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-22-177777
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312522177777/0001193125-22-177777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312522177777/d330381d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-177777
- JSON: https://secwatch.observer/filing/0001193125-22-177777.json
- Plain text: https://secwatch.observer/filing/0001193125-22-177777.txt

## Key facts
- Executive change
  Anand Shah resigned as director at Invivyd, Inc..
  - Action: resigned
  - Role: director
  source text: On June 17, 2022, Anand Shah, M.D. notified Adagio Therapeutics, Inc. (the “Company”) of his decision to resign from the board of directors of the Company and all committees thereof, effective immediately following adjournment of the Company’s 2022 annual meeting of stockholders, which will be held on June 22, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832038/000119312522177777/0001193125-22-177777-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.